Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome

Journal of Neuroimmunology

Volumn 174, Issue 1-2, 2006, Pages 12-20

  Caporale, Christina M ^a   Capasso, Margherita ^a   Luciani, Mirella ^b   Prencipe, Vincenza ^b   Creati, Beatrice ^b   Gandolfi, Paola ^b   De Angelis, Maria V ^a   Di Muzio, Antonio ^a   Caporale, Vincenzo ^b   Uncini, Antonino ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Experimental Zooprophylactic Institute G Caporale   (Italy)

Author keywords

Antigangliosides antibodies; Axonopathy; Campylobacter jejuni; GBS animal model; Immunization; Keyhole lympet hemocyanin; Lipopolysaccharide

Indexed keywords

FREUND ADJUVANT; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; KEYHOLE LIMPET HEMOCYANIN; LIPOPOLYSACCHARIDE; BACTERIUM ANTIBODY; EPITOPE; GANGLIOSIDE; GANGLIOSIDE, GD1A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CAMPYLOBACTER JEJUNI; GUILLAIN BARRE SYNDROME; IMMUNIZATION; MALE; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROPATHY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SCIATIC NERVE; TITRIMETRY; WEAKNESS; ANIMAL; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; IMMUNOLOGY; METHODOLOGY; MICROBIOLOGY; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYRADICULONEUROPATHY; TIME; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; CAMPYLOBACTER JEJUNI; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; G(M1) GANGLIOSIDE; GANGLIOSIDES; GENE EXPRESSION; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNIZATION; LIPOPOLYSACCHARIDES; MALE; POLYRADICULONEUROPATHY; RABBITS; TIME FACTORS;

EID: 33745597404     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.12.005     Document Type: Article

References (55)

1. Analysis of covariance performed in agreement with post hoc statistical procedures: analysis of covariance. University of Colorado at Colorado Springs, Colorado, USA (http://web.uccs.edu/lbecker/Psy590/ancova2.htm#Overview).
2. Ang C.W., Endtz H.P., Jacobs B.C., Laman J.D., De KlerK M.A., van der Meché F.G.A., and Van Doorn P.A. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits. J. Neuroimmunol. 104 (2000) 133-138
3. Ang C.W., De Klerk M.A., Endtz H.P., Jacobs B.C., Laman J.D., van der Meche F.G., and van Doorn P.A. Guillain-Barré syndrome and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits. Infect. Immun. 69 (2001) 2462-2469
4. Aspinall G.O., Fujimoto S., McDonald A.G., Pang H., Kurjanczyk L.A., and Penner J.L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human ganglioside in structure. Infect. Immun. 62 (1994) 2122-2125
5. Aspinall G.O., McDonald A.G., Pang H., Kurjanczyk L.A., and Penner J.L. Lipopolysaccharides of Campylobacter jejuni serotype O:19 structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33 (1994) 241-249
6. Capasso M., Caporale C.M., Pomilio F., Gandolfi P., Lugaresi A., and Uncini A. Acute motor conduction block neuropathy: another Guillain-Barré syndrome variant. Neurology 61 (2003) 617-622
7. Corbo M., Quattrini A., Latov N., and Hays A.P. Localization of GM1 and Gal(β1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 43 (1993) 809-814
8. De Libero G., Moran A.P., Gober H.J., Rossy E., Shamshiev A., Chelnokova O., Mazorra Z., Vendetti S., Sacchi A., Prendergast M.M., Sansano S., Tonevitsky A., Landmann R., and Mori L. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22 (2005) 763-772
9. Doherty P., and Walsh F.S. Ganglioside GM1 antibodies and B-cholera toxin bind specifically to embryonic chick dorsal root ganglion neurons but do not modulate neurite regeneration. J. Neurochem. 48 (1987) 1237-1244
10. Dyck P.J., Giannini C., and Lais A. Pathologic alteration of nerves. In: Dyck P.J., and Thomas P.K. (Eds). Peripheral Neuropathy (1993), WB Saunders Co, Philadelphia 514-595
11. Feasby T.E., Gilbert J.J., Brown W.F., Bolton C.F., Hahn A.F., Koopman W.F., and Zochodne D.W. An acute axonal form of Guillain-Barré polyneuropathy. Brain 109 (1986) 1115-1126
12. Freimer M.L., McIntosh K., Adams R.A., Alving C.R., and Drachman D.B. Gangliosides elicit a T-cell independent antibody response. J. Autoimmun. 6 (1993) 281-289
13. Griffin J.W., Li C.Y., Ho T.W., Xue P., Macko C., Gao C.Y., Yang C., Tian M., Mishu B., Cornblath D.R., McKhann G.M., and Asbury A.K. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118 (1995) 577-595
14. Guerry P., Szymanski C.M., Prendergast M.M., Hickey T.E., Ewing C.P., Pattarini D.L., and Moran A.P. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect. Immun. 70 (2002) 787-793
15. Harris J.R., and Markl J. Keyhole limpet hemocyanin (KLH): a biochemical review. Micron 30 (1999) 597-623
16. Harvey G.K., Toyka K.V., Zielasek J., Kiefer R., Simonis C., and Hartung H.P. Failure of the anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 18 (1995) 388-394
17. Hirota N., Kaji R., Bostock H., Shindo K., Kawasaki T., Mizutani K., Oka N., Kohara N., Saida T., and Kimura J. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane current in single motor neurons. Brain 120 (1997) 2159-2169
18. Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., Asbury A.K., Blaser M.J., and McKhann G.M. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118 (1995) 597-605
19. Ho T.W., Hsiek S.T., Nachamkin I., Willison H.J., Sheikh K., Kielbauch J., Flanigan K., McArthur J.C., Cornblath D.R., McKhann G.M., and Griffin J.W. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 48 (1997) 717-724
20. Ho T.W., Willison H.J., Nachamkin I., Li C.Y., Veitch J., Hung H., Wang G.R., Liu R.C., Cornblath D.R., Asbury A.K., Griffin J.W., and McKhann G.M. Anti GD1a antibody is associated with axonal but not demyelinating form of Guillain-Barré syndrome. Ann. Neurol. 45 (1999) 168-173
21. Jacobs J.M., and Love S. Qualitative and quantitative morphology of human sural nerve at different ages. Brain 108 (1985) 897-924
22. Karkhanis Y.D., Zeltner J.Y., Jackson J.J., and Carlo D.J. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal. Biochem. 85 (1978) 595-601
23. Koga M., Tatsumoto M., Yuki N., and Hirata K. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 71 (2001) 123-124
24. Kusunoki S., Chiba A., Kon K., Ando S., Arisawa K., Tate A., and Kanazawa I. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 35 (1994) 570-576
25. Kusunoki S., Iwamori M., Chiba A., Hitoshi S., Arita M., and Kanazawa I. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology 47 (1996) 237-242
26. Kuwabara S., Yuki N., Koga M., Hattori T., Matura D., Miyake M., and Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann. Neurol. 44 (1998) 202-208
27. Laemmli U.K. Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227 (1970) 680-685
28. Lee G., Jeong Y., Wirguin I., Hays A.P., Willison H.J., and Latov N. Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni. J. Neuroimmunol. 146 (2004) 63-75
29. Lugaresi A., Ragno M., Torrieri F., Di Guglielmo G., Fermani P., and Uncini A. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J. Neurol. Sci. 147 (1997) 193-200
30. McKhann G.M., Cornblath D.R., Griffin J.W., Ho T.W., Li C.Y., Jiang Z., Wu H.S., Zhaori G., Liu Y., Jou L.P., Liu T.C., Gao C.Y., Mao J.Y., Blaser M.J., Mishu B., and Asbury A.K. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33 (1993) 333-342
31. Mills S.D., Bradbury W.C., and Penner J.L. Basis foe serological heterogeneity of thermostable antigens of Campylobacter jejuni. Infect. Immun. 50 (1985) 284-291
32. Nachamkin I., Ung H., Moran A.P., Yoo D., Prendergast M.M., Nicholson M.A., Sheikh K., Ho T., Asbury A.K., McKhann G.M., and Griffin J.W. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J. Infect. Dis. 179 (1999) 1183-1189
33. Paparounas K., O'Hanlon G.M., O'Leary C.P., Rowan E.G., and Willison H.J. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain 122 (1999) 807-816
34. Prendergast M.M., Kosunen T.U., and Moran A.P. Development of an immunoassay for rapid detection of ganglioside GM1 mimicry in Campylobacter jejuni strains. J. Clin. Microbiol. 39 (2001) 1494-1500
35. Preston M.A., and Penner J.L. Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni. Infect. Immun. 55 (1987) 1806-1812
36. Rees J.H., Soudain S.E., Gregson N.A., and Hughes R.A. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333 (1998) 1374-1379
37. Santoro M., Uncini A., Corbo M., Staugaitis S.M., Thomas F.P., Hays A.P., and Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann. Neurol. 31 (1992) 385-390
38. Sargent E.R., and Williams R.D. Immunotherapeutic alternatives in superficial bladder cancer. Interferon, interleukin-2, and keyhole limpet hemocyanin. Urol. Clin. North Am. 19 (1992) 581-589
39. Susuki K., Nishimoto Y., Yamada M., Baba M., Ueda S., Hirata K., and Yuki N. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann. Neurol. 54 (2003) 383-388
40. Susuki K., Nishimoto Y., Koga M., Nagashima T., Mori I., Hirata K., and Yuki N. Various immunization protocols for an acute motor axonal neuropathy rabbit model compared. Neurosci. Lett. 368 (2004) 63-67
41. + currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37 (1995) 436-442
42. Thomas F.P., Trojaborg W., Nagy C., Santoro M., Sadiq S.A., Latov N., and Hays A.P. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 82 (1991) 378-383
43. Uncini A., and Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor terminal block. Muscle Nerve 22 (1999) 640-644
44. Uncini A., Santoro M., Corbo M., Lugaresi A., and Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16 (1993) 610-615
45. van der Meche F.G., van Doorn P.A., Meulstee J., and Jennekens F.G. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur. Neurol. 45 (2001) 133-139
46. Westphal O., and Jann K. Bacterial lipopolysaccharides, extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem. 5 (1965) 83-91
47. Willison H.J., Veitch J., Swan A.V., Baumann N., Comi G., Gregson N.A., Illa I., Jacobs B.C., Zielasek J., and Hughes R.A. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur. J. Neurol. 6 (1999) 71-77
48. Wirguin I., Suturkowa-Milosevic L., Briani C., and Latov N. Keyhole limpet hemocyanin contains Gal(β1-3)-GalNac determinants that are cross-reactive with the T antigen. Cancer Immunol. Immunother. 40 (1995) 307-310
49. Wirguin I., Briani C., Suturkowa-Milosevic L., Fisher T., Della-Latta P., Chalif P., and Latov N. Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides. J. Neuroimmunol. 78 (1997) 138-142
50. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet, Infect. Dis. 1 (2001) 29-37
51. Yuki N., Noshino H., Sato S., and Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40 (1990) 1900-1902
52. Yuki N., Noshino H., Sato S., Shinozawa K., and Miyatake T. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15 (1992) 899-903
53. Yuki N., Taki T., Inagaki F., Kasawa T., Takahashi M., Saito K., Handa S., and Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178 (1993) 1771-1775
54. Yuki N., Yamada M., Koga M., Odaka M., Susuki K., Tagawa Y., Ueda S., Kasama T., Ohnishi A., Hayashi S., Takahashi H., Kamijo M., and Hirata K. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49 (2001) 712-720
55. Yuki N., Susuki K., Koga M., Nishimoto Y., Odaka M., Hirata K., Taguchi K., Miyatake T., Furukawa K., Kobata T., and Yamada M. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11404-11409